Google’s Isomorphic Labs to raise over $2 billion in new fundingAlphabet's AI drug discovery firm, Isomorphic Labs, is reportedly close to securing over $2 billion in new funding, led by Thrive Capital. ...
Why are US stock market indexes up today, and will S&P 500, Nasdaq and Dow Jones stay in green or turn red again? Wall Street April gains, biggest gainers and losers, analysts insights and market outlookWhy are US stock market indexes up today, and will S&P 500, Nasdaq and Dow Jones stay in green or turn red again? US stocks closed higher a...
Global Markets | European equities log steep weekly losses with no resolution to MidEast conflictEuropean stocks saw a significant weekly drop Friday. Investors are concerned about growth and inflation due to Middle East conflict disrup...
Wall Street Week Ahead: Soaring US stocks face pivotal week of tech-led earnings, Fed meetingIndian markets brace for a crucial week. Major tech giants like Microsoft and Alphabet report earnings. Investors watch for clues on artifi...
When does the Boston marathon start? Tracker on runners, route, live stream, results and all detailsRace day has arrived for the 130th Boston Marathon, with approximately 30,000 runners tackling the 26.2-mile course from Hopkinton to Boyls...
Abhishek Bachchan reveals how he and Aishwarya Rai raised daughter Aaradhya: ‘There’s no competition about….’Abhishek Bachchan shares his parenting philosophy with wife Aishwarya Rai Bachchan. They focus on living by example for daughter Aaradhya. ...
Eli Lilly (LLY) stock soars after FDA approves Foundayo - can this weight-loss pill drive massive growth as investors bet big on obesity drug boomEli Lilly (LLY) stock today: Eli Lilly's stock surged over 5% following the US FDA's approval of its new oral weight-loss drug, Foundayo. T...
School assembly news headlines for April 2: Top national, international, business, sports update and thought of the dayToday's school assembly bulletin for April 2 covers significant national news, including bail granted in a Goa nightclub fire case and the ...
Cipla launches drug for obesity, diabetesCipla has launched Yurpeak, a new injectable medication for obesity and type-2 diabetes. This one-weekly therapy, tirzepatide, is now avail...
Eli Lilly becomes first healthcare firm to hit $1 trillion market cap - here’s why LLY stock has jumped over 36% this yearEli Lilly stock today: Eli Lilly achieved a historic milestone, briefly touching a $1 trillion market cap. This success is driven by strong...
Cipla to sell Lilly's weight-loss drug in IndiaEli Lilly and Cipla have joined forces. Cipla will now market Lilly's popular weight-loss drug in India. The medication will be sold under ...
Eli Lilly and Visa expected to hit $1 trillion valuation by 2030: Here’s what’s driving the surgeAs global equity markets expand, two corporate heavyweights are emerging as serious contenders to reach $1 trillion in market capitalizatio...
Twitter prank spurs unexpected scrutiny of insulin pricesAmong the victims was drugmaker Eli Lilly, whose stock price nosedived -- erasing billions in market capitalization -- after a parody accou...
Eli Lilly's new diabetes drug could boost the stock, says SVB SecuritiesSVB Securities believes that the new diabetes drug by Eli Lilly might be able to address patients' obesity and might lead to more significa...
Eli Lilly to expand diabetes treatment portfolio in IndiaThe company that sells a range of medicines and drug delivery devices in the diabetes segment is awaiting regulatory approval for the new p...
Eli Lilly aims to be among top 20 pharma companies in India by 2020The company lays maximum emphasis on its diabetes portfolio and would be introducing new products to cater to over 60 million patients in t...
- Boehringer Ingelheim, Eli Lilly launch Linagliptin tablets
Boehringer Ingelheim India and Eli Lilly and Company India (Lilly) today said they have launched Linagliptin tablets used for treating diab...